SCHEMBL10015993

SCHEMBL10015993

C=c1ccc2c(c1)Oc1cc(O)ccc1C=2c1ccc(NC(=S)C(C)(C)C)cc1C(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FTO Q9C0B1 4/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.33
▸ BRCA1 P38398 1/20 0.33
▸ YWHAG P61981 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ KEAP1 Q14145 1/20 0.33
▸ NFE2L2 Q16236 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CA1 P00915 6/20 0.31
▸ CA2 P00918 6/20 0.31
▸ CA9 Q16790 6/20 0.31
▸ KDM4C Q9H3R0 1/20 0.31
▸ CA12 O43570 3/20 0.31
▸ CA4 P22748 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17917406 0.84 FTO (0.48) FTOHSD17B10MEN1USP2POLB
SCHEMBL12291666 0.83 KDM4C (0.40) MEN1KMT2ACA1CA2CA9
SCHEMBL19749039 0.82 HSD17B10 (0.35) HSD17B10MEN1USP2POLBHSP90AA1
SCHEMBL12171475 0.81 MEN1 (0.39) HSD17B10MEN1USP2POLBHSP90AA1
SCHEMBL12678084 0.80 HSD17B10 (0.38) HSD17B10MEN1USP2POLBHSP90AA1
SCHEMBL14620246 0.79 HSD17B10 (0.39) HSD17B10MEN1USP2POLBHSP90AA1
SCHEMBL12926177 0.78 MEN1 (0.53) FTOHSD17B10MEN1USP2POLB
SCHEMBL19749041 0.77 MEN1 (0.37) HSD17B10MEN1USP2POLBHSP90AA1
SCHEMBL19543149 0.77 HSD17B10 (0.36) HSD17B10MEN1USP2POLBHSP90AA1
SCHEMBL17930252 0.77 MEN1 (0.39) HSD17B10MEN1USP2POLBHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9889213-B2 Multimodal imaging of fibrin THE GENERAL HOSPITAL CORPORATION (US) 2018-02-13 — — US disclosed
US-20160199519-A1 Multimodal Imaging of Fibrin THE GENERAL HOSPITAL CORPORATION 2016-07-14 — — US disclosed
US-9200017-B2 Multimodal imaging of fibrin THE GENERAL HOSPITAL CORPORATION (US) 2015-12-01 — — US disclosed
US-20120077958-A1 Multimodal Imaging of Fibrin THE GENERAL HOSPITAL CORPORATION 2012-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077958-A1 Multimodal Imaging of Fibrin FGB, F2, SERPINC1 FTO 2886/4885HSD17B10 3821/4885MEN1 605/4885
US-20160199519-A1 Multimodal Imaging of Fibrin FGB, F2, SERPINC1 FTO 2886/4885HSD17B10 3821/4885MEN1 605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback